Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00107094
Status:
COMPLETED
Last Update Posted:
2007-07-20
First Post:
2005-04-05
Brief Title:
Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer
Sponsor:
Celgene Corporation
Organization:
Celgene Corporation